On the contrary, when MIP-CWS was tested in B16-F10 melanoma-bearing mice and due to its capacity to induce Th2, a worse antitumor effect was obtained compared to MIP-CW [76] or whole MIP [77] (see Section 3.2). Here, MIP is linked to melanoma.